Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS ) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.

ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading.


You are viewing a robot-friendly page.Click hereto reload in standard format.